L&G Pharma Breakthrough UCITS ETF
ETLI.DE
#3180
ETF rank
C$25.92 M
Marketcap
๐Ÿ‡ช๐Ÿ‡บ EU
Market
C$18.85
Share price
0.97%
Change (1 day)
26.91%
Change (1 year)

Expense ratio and fees for L&G Pharma Breakthrough UCITS ETF (ETLI.DE)

Total Expense Ratio

Total Expense Ratio as of November 2025: 0.49%

ter

ter as of June 2026: 0.49%